Browse by Subject TYROSINE KINASE INHIBITOR

Showing results 1 to 4 of 4

1
APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis

Hong, Se-Hoon; Lee, Won Jae; Kim, Young Doo; Kim, Hyunjoo; Jeon, Young-Jun; Lim, Bitna; Cho, Dong-Hyung; et al, ONCOTARGET, v.7, no.16, pp.21601 - 21617, 2016-04

2
Development and Biological Evaluation of Potent and Selective c-KITD816V Inhibitors

Lee, So Young; Lee, Hyunseung; Kim, Jin Hee; Lee, Suhyun; Kim, Soo Jung; Choi, Byong-Seok; Hong, Soon-Sun; et al, JOURNAL OF MEDICINAL CHEMISTRY, v.57, no.15, pp.6428 - 6443, 2014-08

3
Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs

Lee, Choong-kun; Kim, Sora; Lee, Jae Seok; Lee, Jeong Eun; Kim, Sung-moo; Yang, In Seok; Kim, Hye Ryun; et al, LUNG CANCER, v.113, pp.106 - 114, 2017-11

4
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms

Aldonza, Mark Borris D.; Ku, Jayoung; Hong, Ji-Young; Kim, Donghwa; Yu, Seung Jung; Lee, Min-Seok; Prayogo, Monica Celine; et al, SCIENCE ADVANCES, v.6, no.6, 2020-02

rss_1.0 rss_2.0 atom_1.0